U.S. market Closed. Opens in 26 minutes

SONN | Sonnet BioTherapeutics Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue18.63K147.81K349.94K483.63KN/A40.61M30.73M41.43M41.70M42.40MN/A17.50M6.88M1.46M136.30K684.67K234.06K
Cost of RevenueN/A11.81M93.26K16.63M58.31K7.93M29.94M39.41M38.38M14.04MN/AN/A2.76M360.81K11.08K684.67K234.06K
Gross Profit18.63K-11.67M256.69K-16.15M-58.31K32.68M791.11K2.03M3.33M28.36MN/A17.50M4.12M1.10M125.22KN/AN/A
Operating Expenses11.87M18.94M30.02M25.57M17.41M4.71M3.86M4.55M5.95M10.78MN/A-23.29M2.62M1.25M935.11K1.12M1.14M
Selling, General & Admin6.13M7.13M8.58M8.94M7.53M2.51M3.86M4.55M5.95M7.42MN/AN/A2.62M1.25M935.11K2.24M2.27M
Research & Development5.74M11.81M21.44M16.63M9.88M2.20M154.72KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/A125.50KN/A11.05M11.05M5.19M3.45M3.36MN/A-23.29MN/AN/AN/A-1.12M-1.14M
Operating Income-11.85M-18.79M-29.67M-25.09M-24.24M-4.71M-3.07M-2.52M-2.62M-11.49MN/A-5.80M-2.87M-714.30K-809.89K-444.49K-949.99K
Other Expenses / Income4.41M-40.08K-52.48K103.47K-27.34K-162.87K-7.38M-5.29M-1.53M3.59MN/A508.78K-505.46K-379.90K-220.03K-369.21K-1.29M
Before Tax Income-7.44M-18.83M-29.72M-24.98M-24.27M-4.87M-8.07M-7.81M-4.15M-14.32MN/A-5.96M-3.38M-1.09M-1.03M-813.70K-2.24M
Income Tax ExpensesN/AN/A52.48K22.03K6.80M162.87K-701.22K-644.43K198.46K-187.57KN/AN/A19.20K14.61KN/AN/AN/A
Net Income-7.44M-18.83M-29.77M-25.01M-31.06M-5.03M-6.85M-6.79M-9.08M-12.14MN/A-5.96M-3.17M-1.10M-1.01M-813.70K-2.24M
Interest ExpensesN/AN/AN/AN/A20.68K162.87K381.68K-2.59M-2.35M-3.47MN/AN/A-474.93K-180.82K140.02K33.91K20.49K
Basic Shares Outstanding655.24K1.04M197.46K79.70K30.59K871.00439.00315.00270.00284.00191.0087.002.54M2.37M5.001.001.00
Diluted Shares Outstanding655.24K1.04M197.46K79.70K30.59K871.00439.00315.00270.00284.00191.0087.002.54M2.37M5.001.001.00
EBITDA-11.85M-18.72M-29.58M-24.99M-24.24M-13.15M-3.71M-2.93M541.15K-2.73MN/A-3.91M-3.24M-1.18M-878.82K-376.05K-2.21M
EBITDA Margin-63,617.91%-12,663.22%-8,451.69%-5,167.69%0.00%-32.38%-12.06%-7.08%1.30%-6.44%0.00%-22.33%-47.06%-80.75%-644.76%-54.92%-942.91%
EBIT-7.44M-18.83M-29.72M-24.98M-24.24M-4.71M-7.17M-10.03M-11.23M-15.79MN/A-5.96M-3.62M-1.27M-871.55K-779.78K-2.22M
EBIT Margin-39,929.30%-12,741.58%-8,493.34%-5,165.97%0.00%-11.59%-23.34%-24.21%-26.92%-37.25%0.00%-34.07%-52.63%-86.73%-639.43%-113.89%-947.69%
Financial Year End2024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙